Endometriosis and gynaecological cancers: molecular insights behind a complex machinery

. 2021 Dec ; 20 (4) : 201-206. [epub] 20211206

Status PubMed-not-MEDLINE Jazyk angličtina Země Polsko Médium print-electronic

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid35069072

Endometriosis is described as the presence of both endometrial glandular and stromal cells outside the uterine cavity. A major characterization of this disease is ectopic implantation of endometrial cells with increased migration. It is one of the leading causes of morbidity among premenopausal women, with a prevalence of 10-16% of women of reproductive age. Despite over century of intensive research, none of the current treatment options represents a real cure. Based on the current knowledge, endometriosis, particularly its atypical version, is considered to be a transitional form from benign disease to tumour. However, the exact mechanisms of this conversion are still not fully established.

Zobrazit více v PubMed

Kralickova M, Vetvicka V, Fiala L, et al. . The search for biomarkers in endometriosis: a long and windy road. Reprod Sci 2021. PubMed

Kajihira H, Yamada Y, Kanayama S, et al. . New insight into the pathology of endometriosis: from chronic inflammation to danger signal. Gynecol Endocrinol 2011; 2: 73-79. PubMed

Szamatowicz M, Hermanowicz-Szamatowicz K. Endometriosis–a decade later–still an enigmatic disease. What is the new in the diagnosis and treatment? Oncol Endocrinol 2020; 36: 104-108. PubMed

Lagana AS, Garzon S, Gotte M, et al. . The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci 2019; 20: 5615. PubMed PMC

Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg 1925; 10: 1-72.

Scott RB. Malignant change in endometriosis. Obstet Gynecol 1953; 2: 283-289. PubMed

Kralickova M, Vetvicka V, Lagana AS. Endometrial cancer–is our knowledge changing? Transl Cancer Res 2020; 9: 7734-7745. PubMed PMC

Pearce CL, Templeman C, Rossing MA, et al. . Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13: 385-394. PubMed PMC

Levin G, Cheng C, Healey M, et al. . Endometriosis–it is not just beginning. J Gynecol Obste Human Reprod 2020; 49: 101744. PubMed

Olovsson M. Immunological aspects of endometriosis: An update. Am J Reprod Immunol 2011; 66 (Suppl.1): 101-114. PubMed

Vlahos NF, Kalampokas T, Fotiou S. Endometriosis and ovarian cancer. A review. Gynecol Endocrin 2010: 26: 213-219. PubMed

Hunn, J, Rodriquez, GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 2012; 1: 3-23. PubMed

Ralaitzopoulos DR, Mitsopoulou A, Illiopoulou SM, et al. . Association between endometriosis and gynecological cancers: a critical review of the literature. Arch Gynecol Obstetr 2020; 301: 355-367. PubMed

Ota Y, Ota K, Takahashi T, et al. . Primary endometrioid carcinoma of the uterosacral ligament arising from deep infiltrating endometriosis 6 years after bilateral salphingo-oophorectomy due to atypical proliferative endometrioid tumor of the ovary: a rare case report. World J Surg Oncol 2020; 18: 329. PubMed PMC

Pan Q, Luo X, Toloubeydokhti T, et al. . The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007; 13: 797-806. PubMed

Nakamura N, Terai Y, Nunode M, et al. . The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer. J Ovar Canc 2020; 13: 51. PubMed PMC

Suryawanshi S, Vlad AM, Lin HM, et al. . Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2013; 19: 1213-1224. PubMed PMC

Wu RL, Ali S, Bandyopadhyay S, et al. . Comparative analysis of differentially expressed miRNAs and their downstream mRNAs in ovarian cancer and its associated endometriosis. J Cancer Sci Ther 2015; 7: 258-265. PubMed PMC

Kralickova M, Vetvicka V. Endometriosis and ovarian cancer. World J Clin Oncol 2014; 5: 800-805. PubMed PMC

Gadducci A, Zannoni GF. Endometriosis-associated extraovarian malignancies: a challenging question for the clinician and the pathologist. Anticancer Res 2020; 40: 2429-2438. PubMed

Hermens M, van Altena AM, van der Aa M, et al. . Ovarian cancer prognosis in women with endometriosis: a retrospective nationwide cohort study of 32,419 women. Am J Obst Gynecol 2021; 224: 284.e1-284.e10. PubMed

Hermens M, van Altena AM, Niebort TE, et al. . Incidence of endometroid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study. Am J Obstet Gynecol 2020; 223: 107.e1-11. PubMed

Buis CC, van Leeuwen FE, Mooiji TM, et al. . OMEGA Project Group. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod 2013; 28: 3358-3369. PubMed

Pearce CL, Templeman C, Rossing MA, et al. . Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13: 385-394. PubMed PMC

Dzatic-Smiljkovic O, Vasiljevic M, Djukic M, et al. . Frequency of ovarian endometriosis in epithelial ovarian cancer patients. Clin Exp Obstet Gynecol 2011; 38: 394-398. PubMed

La Grenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988; 19: 1080-1084. PubMed

Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999; 91: 1459-1467. PubMed

Wang C, Liang Z, Liu X, et al. . The association between endometriosis, tubal ligation, hysterectomy and epithelial ovarian cancer: meta-analyses. Int J Environ Res Public Health 2016; 13: 1138. PubMed PMC

Kobayashi H. Potential scenarios leading to ovarian cancer arising from endometriosis. Redox Rep 2016; 21: 119-126. PubMed PMC

Murakami K, Kotani Y, Nakai H, et al. . Endometriosis-associated ovarian cancer: the origin and targeted therapy. Cancers 2020; 12: 1676. PubMed PMC

Brinton LA, Sakoda LC, Sherman ME, et al. . Relatioship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarker Prev 2005; 14: 2929-2935. PubMed

Sayasneh A, Tsivos D, Crawford R. Endometriosis and ovarian cancer: a systematic review. ISRN Obstet Gyn 2011; 2011: 140310. PubMed PMC

Kondi-Pafiti A, Papakonstantinou E, Iavazzo C, et al. . Clinicopathological characteristics of ovarian carcinomas associated with endometriosis. Arch Gynecol Obstet 2012; 285: 479-483. PubMed

Pejovic T, Thisted S, White M, et al. . Endometriosis and endometriosis-associated ovarian cancer (EAOC). Adv Exp Med Biol 2020; 1242: 73-87. PubMed

Wei JJ, William J, Bulun S. Endometriosis and ovarian cancer: a review of clinical, pathologi, and molecular aspects. Int J Gynecol Pathol 2011; 20: 553-568. PubMed PMC

Kumar S, Munkarah A, Arabi H, et al. . Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol 2011; 204: 63.e1. PubMed

Kok VC, Tsai HJ, Su CF, et al. . The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study. Int J Gynecol Cancer 2015; 25: 968-976. PubMed

Chiang AJ, Chang C, Huang CH, et al. . Risk factors in progression from endometriosis to ovarian cancer: a cohort study based on medical insurance data. J Gynecol Oncol 2018; 29: e28. PubMed PMC

Eoh KJ, Han M, Kim EH, et al. . Markedly increased risk of malignancies in women with endometriosis. Gynecol Oncol 2021; 161: 291-296. PubMed

Bertelsen L, Mellemkjaer L, Frederiksen K, et al. . Risk for breast cancer among women with endometriosis. Int J Cancer 2007; 120: 1372-1375. PubMed

Lu J, Tao X, Zhou J, et al. . Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis. Oncotarget 2017; 8: 5843-5852. PubMed PMC

Koiyama S, Aoki D, Tominagha E, et al. . Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis. Clinicopathologic evaluation. Gynecol Oncol 1999; 72: 342-346. PubMed

Noli S, Cipriani S, Scarfone G, Villa A, et al. . Long term survival of ovarian endometriosis associated clear cell and endometriod ovarian cancers. Int J Gynecol Canc 2013; 23: 244-248. PubMed

Bounous VE, Ferrero A, Fuso L, et al. . Endometriosis-associated ovarian cancer: a distinct clinical entity? Anticancer Res 2016; 36: 3445-3449. PubMed

Shin HY, Yang W, Chay DB, et al. . Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma. Mol Oncol 2021; 15: 987. PubMed PMC

Wilbur MA, Shih IM, Segars JH, et al. . Cancer implications for patients with endometriosis. Semin Reprod Med 2017; 35: 110-116. PubMed

Wiegand KC, Shah SP, Al-Agha OM, et al. . ARID1A mutations in endometriosis-associated ovarian carcinomas. N Eng J Med 2010; 363: 1532-1543. PubMed PMC

Bhyan SB, Zhao L, Wee YK, et al. . Genetic links between endometriosis and cancer in women. Peer J 2019; 7: e8135. PubMed PMC

Jonusiene V, Sasnauskiene A. Notch and endometrial cancer. Exp Med Biol 2021; 1287: 47-57. PubMed

Kobayashi H. Potential scenarios leading to ovarian cancer arising from endometriosis. Redox Rep 2016; 21: 119-126. PubMed PMC

Fontana J, Zima M, Vetvicka V. Biological markers of oxidative stress in cardiovascular diseases: after so many studies, what do we know? Immunol Invest 2018; 47: 823-843. PubMed

Huang CY, Cheng NM, Wang, PH. Risk factors associated with epithelial ovarian cancer in women with endometriosis. Taiwanese J Obstet Gynecol 2020; 59: 353-355. PubMed

Kralickova M, Vetvicka V. Immunological aspects of endometriosis: a review. Ann Transl Med 2015; 3: 153. PubMed PMC

Vogel TJ, Knickerbocker A, Shah CA, et al. . An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers. J Gynecol Oncol 2015; 26: 25-31. PubMed PMC

Cintesun FNI, Kerumoglu OS, Cintesun E, et al. . The relation between KRAS LCS6 polymorphism and endometrium cancer. J Obstet Gynecol 2020; 40: 988-993. PubMed

Konno T, Kohno T, Okada T, et al. . ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer. Histochem Cell Biol 2020; 154: 197-213. PubMed

Kobayashi H. Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis. Int J Clin Oncol 2009; 14: 378-382. PubMed

Van Leeuwen FE, Klip H, Mooij TM, et al. . Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Human Reprod 2011; 16: 3456-3465 . PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...